Investors Alert – Yahoo! (NASDAQ:YHOO) , Reynolds American (NYSE:RAI) , CNO Financial (NYSE:CNO) , Endo International PLC (NASDAQ:ENDP) , Ennis (NYSE:EBF)

Yahoo Inc. (NASDAQ:YHOO) said Monday it would buy mobile analytics startup Flurry Inc. for a reported $300 million, with teams from Weil Gotshal & Manges LLP and Goodwin Proctor LLP advising on either side of the deal. Yahoo! Inc. (NASDAQ:YHOO) stock performance was 0.96% in last session and finished the day at $33.60. Traded volume was 18.16million shares in the last session and the average volume of the stock remained 19.72million shares. The beta of the stock remained 1.01. Yahoo! Inc. (NASDAQ:YHOO) insider ownership is 0.40%.

Reynolds American Inc. (NYSE:RAI) agreed this month to buy Lorillard Inc., the largest U.S. maker of menthol cigarettes, for $25 billion. If the deal is cleared by antitrust regulators, the transaction will leave the 400-year-old American tobacco industry with just Reynolds and Altria Group Inc. controlling 90 percent of the market. Reynolds American, Inc. (NYSE:RAI) rose 0.31 percent to $58.16 Tuesday on volume of 2.86million shares. The intra-day range of the stock was $58.05 to $58.96. Reynolds American, Inc. (NYSE:RAI) has a market capitalization of $31.18billion.

FBR Capital Markets reiterated their outperform rating on shares of CNO Financial Group (NYSE:CNO) in a research note released on Friday morning. They currently have a $21.00 target price on the stock, up from their previous target price of $20.00. CNO Financial Group Inc (NYSE:CNO)’s stock on July 22, 2014 reported a increase of 0.53% to the closing price of $17.15. Its fifty two weeks range is $13.57 -$19.34. The total market capitalization recorded $3.74billion. The overall volume in the last trading session was 1.01million shares. In its share capital, CNO has 217.85million outstanding shares.

Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ:ENDP) (ENL.TO), and BioDelivery Sciences International, Inc. (BDSI) announced on July 7 positive top-line results from its pivotal Phase III efficacy study of BEMA buprenorphine in opioid-experienced patients. BEMA buprenorphine is being developed for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate in both patients who are opioid naive and opioid experienced. On Tuesday, shares of Endo International PLC (NASDAQ:ENDP) advanced 1.35% to close the day at $69.57. Company return on investment (ROI) is -8.50% and its monthly performance is recorded as -0.09%. Endo International PLC (NASDAQ:ENDP) quarterly revenue growth is 13.07%.

Ennis Inc (NYSE:EBF) declared a quarterly dividend on Thursday, June 26th, American Banking reports. Shareholders of record on Monday, July 14th will be given a dividend of 0.175 per share on Friday, August 1st. This represents a $0.70 dividend on an annualized basis and a yield of 4.57%. Ennis, Inc. (NYSE:EBF) stock performance was 0.82% in last session and finished the day at $14.80. Traded volume was 44,790.00million shares in the last session and the average volume of the stock remained 90.74K shares. The beta of the stock remained 1.54. Ennis, Inc. (NYSE:EBF) insider ownership is 3.20%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone